Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > majority of announcements past year

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Mar 16, 2021 8:39pm

146 Views

Post# 32813714

majority of announcements past year

Here are the major announcements for the past year
I ommited financial,AGM meetings etc.

Microbix & Seegene Canada Form COVID-Variant Collaboration…. MAR 15, 2021
Microbix Antigen-test QAPs Now Available For Clinical Use …… MAR 11, 2021
Microbix Announces Quality Products Distribution Agreement….. FEB 16, 2021
Microbix Announces Material First Sales of Viral Transport Medium….. FEB 9, 2021
Microbix Viral Transport Medium Now Available….. JAN 28, 2021
Microbix & Copan Italia Execute Strategic Agreement….. DEC 21, 2020
Microbix Discloses New Products, Sales, And Capacity ….. OCT 29, 2020
Microbix Creates Further COVID-19 Quality Assessment Products….. OCT 20, 2020
Ontario Helps Microbix Ensure Provincial COVID Testing Capacity….. OCT 13, 2020
Microbix’s REDx™ Controls Attain Australian TGA Registration…..SEP 10, 2020
Microbix COVID-19 QAPs Attain EU “CE Mark” Registration……JUN 5, 2020
Microbix Announces Quality Products Distribution Agreement……JUN 4, 2020
Microbix Engaged To Develop & Supply Custom QAPs™…..JUN 2, 2020
Microbix Expanding QAPs™ Production Capacity…..MAY 27, 2020
Microbix Achieves Full Utilization Of Its Bioreactors…..MAY 19, 2020
Microbix Announces Quality Products Distribution Agreement…..MAY 15, 2020
Microbix Announces Quality Products Distribution Agreement……MAY 12, 2020
Microbix COVID-19 QAPs Now Available for U.S. Labs…..MAY 7, 2020
Microbix Begins Providing COVID-19 Test Quality Products…..MAY 6, 2020
Microbix Announces Quality Products Distribution Agreement…..APR 27, 2020
Microbix Attains Health Canada Establishment Licensing……APR 21, 2020
Microbix & Oneworld Create COVID-19 Test Quality Program…..APR 9, 2020
Microbix Creates Quality Assessment Product For COVID-19 Tests…..MAR 30, 2020